HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spain Lists Certain OTCs As 'Essential' In Fight Against COVID-19

Executive Summary

Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.

You may also be interested in...



Spain’s OTC Market Goes Into Reverse After COVID-19 Sales Spike

Sales of self-care products in Spain have dropped below 2019 levels after a huge spike in demand in March as a result of the coronavirus pandemic. However, sales of paracetamol still remain markedly above 2019 levels.

India Eases Paracetamol Export Restrictions

Global supply of paracetamol could soon improve after India said it would allow some exports of the drug. The country introduced severe export restrictions in March to ensure it had a sufficient stockpile of paracetamol to meet internal demand during the COVID-19 outbreak.

COVID-19 Prompts OTC Sales Restrictions Across Europe

Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.

Topics

UsernamePublicRestriction

Register

WI964834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel